GKB Ophthalmics last traded at ₹60.00 (2026-10-13). Over the past month the stock moved -5.7%, three months the stock moved -11.6%, year the stock moved -14.7%. Its closing range over 52 weeks is ₹47.29 – ₹74.85, with the latest close 19.8% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1981, GKB Ophthalmics Ltd is engaged in the manufacture and sale of ophthalmic lenses made up of Glass and Plastic.[1]
Business Overview:[1][2] GKBOL is in the business of manufacturing semi-finished ophthalmic glass and plastic lenses, viz., single-vision glass, single-vision plastic, bifocal plastic and photochromic plastic lenses.
In the latest quarter (Jun 2026), GKB Ophthalmics reported sales of ₹33.04 crore (+2.3%) and net profit of ₹1.85 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 33.04 | 2.63 | 7.96 | 1.85 | 2.00 |
| Mar 2026 | 29.79 | 3.08 | 10.34 | 1.12 | 0.38 |
| Dec 2025 | 56.79 | 1.66 | 2.92 | 0.70 | 0.87 |
| Sep 2025 | 30.17 | 3.02 | 10.01 | 1.84 | 3.17 |
| Jun 2025 | 32.31 | 0.80 | 2.48 | -0.64 | -2.02 |
| Mar 2025 | 31.02 | -2.86 | -9.22 | -4.13 | -7.04 |
| Dec 2024 | 25.80 | -0.94 | -3.64 | -1.91 | -4.03 |
| Sep 2024 | 26.14 | -0.06 | -0.23 | -1.15 | -2.42 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +28.1% | +7.3% | +43.9% | +24.2% | +15.4% | +120.1% | -4.0% | +2.3% |
| Operating profit growth | – | – | – | -23.1% | – | – | – | +228.7% |
| Net profit growth | – | – | – | -681.8% | – | – | – | – |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | -0.2% | -3.6% | -9.2% | 2.5% | 10.0% | 2.9% | 10.3% | 8.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), GKB Ophthalmics reported sales of ₹149.00 crore (+36.7%) and net profit of ₹3.00 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 149.00 | 9.00 | 6.00 | 3.00 | 2.42 |
| Mar 2025 | 109.00 | -3.00 | -3.00 | -7.00 | -13.97 |
| Mar 2024 | 88.00 | 1.00 | 1.00 | -3.00 | -5.57 |
| Mar 2023 | 75.00 | 4.00 | 5.00 | 0.00 | -0.34 |
| Mar 2022 | 71.00 | 5.00 | 7.00 | 2.00 | 2.52 |
| Mar 2021 | 57.00 | 2.00 | 4.00 | -1.00 | -1.81 |
| Mar 2020 | 59.00 | 2.00 | 4.00 | -2.00 | -3.65 |
| Mar 2019 | 57.00 | 1.00 | 2.00 | -1.00 | -2.37 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -26.9% | +3.5% | -3.4% | +24.6% | +5.6% | +17.3% | +23.9% | +36.7% |
| Operating profit growth | +0.0% | +100.0% | +0.0% | +150.0% | -20.0% | -75.0% | -400.0% | – |
| Net profit growth | – | – | – | – | -100.0% | – | – | – |
| EPS growth | – | – | – | – | -113.5% | – | – | – |
| OPM % | 2.0% | 4.0% | 4.0% | 7.0% | 5.0% | 1.0% | -3.0% | 6.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for GKB Ophthalmics.
Get Free AI Stock Analysis FREE →GKB Ophthalmics returns to profitability in FY26 with ₹302.71 lakh net profit - scanx.trade
GKB Ophthalmics Board Meeting Scheduled on May 27, 2026 to Approve Q4 and Full-Year FY26 Financial Results - scanx.trade
GKB Ophthalmics Board Meeting Scheduled on May 27, 2026 to Approve Q4 and Full-Year FY26 Financial Results - scanx.trade
GKB Ophthalmics Board Meeting Scheduled on May 27, 2026 to Approve Q4 and Full-Year FY26 Financial Results - scanx.trade
GKB Ophthalmics Board Meeting Scheduled on May 27, 2026 to Approve Q4 and Full-Year FY26 Financial Results - scanx.trade
GKB Ophthalmics shares were last quoted at ₹60.00 (-0.5% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
GKB Ophthalmics has a price-to-earnings (P/E) ratio of 10.11 and a price-to-book (P/B) ratio of 0.60. The industry P/E is 234.82.
The 52-week high of GKB Ophthalmics is ₹76.90 and the 52-week low is ₹45.25.
The market capitalisation of GKB Ophthalmics is about ₹32.76 crore.
In the latest quarter (Jun 2026), GKB Ophthalmics reported sales of ₹33.04 crore (+2.3%) and net profit of ₹1.85 crore, compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, GKB Ophthalmics has a 3-year ROE of -5.00%, 3-year profit growth of 138.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 51.15% of GKB Ophthalmics.
GKB Ophthalmics belongs to the Medical Equipment/Supplies/Accessories sector.
All Medical Equipment/Supplies/Accessories stocks · Browse all stocks A–Z